Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Pharmacokinetics of pioglitazone in lean and obese cats.

Clark MH, Hoenig M, Ferguson DC, Dirikolu L.

J Vet Pharmacol Ther. 2012 Oct;35(5):428-36. doi: 10.1111/j.1365-2885.2011.01341.x. Epub 2012 May 21.

PMID:
22612529
2.

Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.

Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ.

J Vet Pharmacol Ther. 2011 Jun;34(3):252-8. doi: 10.1111/j.1365-2885.2010.01217.x.

PMID:
21492190
3.

Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.

Clark M, Thomaseth K, Dirikolu L, Ferguson DC, Hoenig M.

J Vet Intern Med. 2014 Jan-Feb;28(1):166-74.

4.

Effect of rifampicin on the pharmacokinetics of pioglitazone.

Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ.

Br J Clin Pharmacol. 2006 Jan;61(1):70-8.

5.

A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.

Vaidyanathan S, Maboudian M, Warren V, Yeh CM, Dieterich HA, Howard D, Dole WP.

Curr Med Res Opin. 2008 Aug;24(8):2313-26. doi: 10.1185/03007990802259354.

PMID:
18786303
6.

The pharmacokinetics of pioglitazone in Thai healthy subjects.

Wittayalertpanya S, Chompootaweep S, Thaworn N.

J Med Assoc Thai. 2006 Dec;89(12):2116-22.

PMID:
17214065
7.

Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.

Sarasola P, Jernigan AD, Walker DK, Castledine J, Smith DG, Rowan TG.

J Vet Pharmacol Ther. 2002 Aug;25(4):265-72.

PMID:
12213114
8.

Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.

Michels GM, Boudinot FD, Ferguson DC, Hoenig M.

Am J Vet Res. 2000 Jul;61(7):775-8.

PMID:
10895899
11.
13.

Pharmacokinetic and bioequivalence study of an oral 8 mg dose of rosiglitazone tablets in Thai healthy volunteers.

Wittayalertpanya S, Chompootaweep S, Thaworn N, Khemsri W, Intanil N.

J Med Assoc Thai. 2010 Jun;93(6):722-8.

PMID:
20572378
14.

[Bioequivalence assessment of pioglitazone hydrochloride oral preparation by limited sampling strategy].

Ding JJ, Jiao Z, Li ZD, Shi XJ.

Yao Xue Xue Bao. 2006 Sep;41(9):893-8. Chinese.

PMID:
17111840
15.

[Pharmacokinetic interaction of pioglitazone hydrochloride and atorvastatin calcium in Beagle dogs].

Chen HL, Zhang WP, Yang FY, Wang XY, Yang WC, Dang HW.

Yao Xue Xue Bao. 2013 May;48(5):741-5. Chinese.

PMID:
23888699
16.

Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.

Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV.

J Clin Pharmacol. 2005 Oct;45(10):1137-44.

PMID:
16172178
17.

In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.

Wong H, Ozalp Y, Lainesse A, Alpan RS.

Arzneimittelforschung. 2004 Sep;54(9A):618-24.

PMID:
15497670
18.
19.

Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.

Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.

Clin Pharmacol Ther. 2005 May;77(5):404-14.

PMID:
15900286
20.

Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.

Choi JS, Koh YY, Chung JH, Choi DH, Han HK.

J Pharm Pharmacol. 2008 Oct;60(10):1403-7. doi: 10.1211/jpp/60.10.0017.

PMID:
18812034

Supplemental Content

Support Center